Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Hldgs Inc (NY: DNA )

1.720 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ginkgo Bioworks Hldgs Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Is It Too Early to Invest in Ginkgo Bioworks?
Ginkgo is on track to easily beat its guidance for 2022. But what about its bottom line? 
Via The Motley Fool
2 Bruised Growth Stocks to Buy While They're Cheap
Both are on the verge of fast growth, and they haven't had any major setbacks yet. 
Via The Motley Fool
The Next Big Disruptors? 3 Biotech Stocks Making Headlines.
Biotech stocks were hard-hit in 2022, but these disruptive names in the field of synthetic biology can be big winners in 2023. 
Via InvestorPlace
3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street
These stocks are risky. But they just might deliver huge gains if analysts are right. 
Via The Motley Fool
3 Penny Stocks That Could Rise 500% in 2023
Tilt the odds in your favor in 2023 with some of these high-potential penny stocks. The risks are high, but so are the rewards. 
Via InvestorPlace
Cathie Wood Keeps Buying Ginkgo Bioworks (DNA) Stock
Ginkgo Bioworks has tumbled this week, but Cathie Wood is among the key buyers of DNA stock, picking up shares yesterday. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 35 companies reached new 52-week lows. 
Via Benzinga
What You Missed On Wall Street On Friday
In the midst of markets falling, some companies had good news, while others took a hit from analysts and a merger is still on hold. 
Via Talk Markets
Three Pharma Stocks to Sell Before They Die
As we head into New Year 2023, these are just some of the top pharma stocks to sell at the start of January. 
Via InvestorPlace
Down 76% This Year, Is This Growth Stock Now a Screaming Buy?
The company's strategy will take time to implement, but it'll make investors a lot richer if it works. 
Via The Motley Fool
Analyzing Ginkgo Bioworks Holdings's Short Interest
Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has fallen 7.31% since its last report. The company recently reported that it has 134.22 million shares sold short, which is 14.71% of all... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday's session, 107 stocks hit new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022
Via Benzinga
2 Biotech Stocks You Can Buy and Hold for the Next Decade
These two companies are facing short-term issues that are likely to give way to long-term success. 
Via The Motley Fool
Looking Into Ginkgo Bioworks Holdings's Recent Short Interest
Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has fallen 14.12% since its last report. The company recently reported that it has 134.22 million shares sold short, which is 15.87% of all... 
Via Benzinga
BrightView Holdings, America's Car-Mart And Some Other Big Stocks Moving Lower On Thursday
U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 79 companies reached new 52-week lows. 
Via Benzinga
Target, Holley, Ferroglobe And Other Big Losers From Wednesday
U.S. stocks closed mostly lower on Wednesday, with the Nasdaq Composite dropping around 175 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Why Ginkgo Bioworks Stock Is Sliding Wednesday Morning
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading lower by 8.63% to $2.44 Wednesday morning. The company during Tuesday's after-hours session announced a public offering of Class A common... 
Via Benzinga
Carnival, Ginkgo Bioworks And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Ginkgo Bioworks Stock Is Down After Hours: What's Happening?
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading lower in Tuesday's after-hours session after the company announced a proposed public offering. 
Via Benzinga
What's Going On With Ginkgo Bioworks Stock After Hours?
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading lower in Monday's after-hours session after the company  
Via Benzinga
3 Unstoppable Stocks That Could Double in 5 Years
The opportunities for these innovators are tremendous. 
Via The Motley Fool
Can Acquisitions and Partnerships Take Ginkgo Bioworks (DNA) Stock Higher?
It seems that Ginkgo Bioworks is announcing a new acquisition or collaboration every day this month, putting DNA stock in focus. 
Via InvestorPlace
Ignore the Hype! These Are 7 of the Worst Stocks to Own Now
Looking for great bear-market bargains? Separate the wheat from the chaff and avoid these seven stocks to sell. 
Via InvestorPlace
5 Top Stocks Cathie Wood Is Buying This Week
In an open letter to the Fed, Cathie Wood notes that deflationary fears could come to fruition, replacing inflationary fears. 
Via InvestorPlace
Morgan Stanley, First Republic Bank And Other Big Losers From Friday
U.S. stocks closed lower on Friday, with the Dow Jones dropping over 400 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
10 Top Stock Market Predictions for 2023
The top stock market predictions for 2023 show that the new year will be one in which hypergrowth stocks dominate. Don't miss out. 
Via InvestorPlace
DFLI Stock Alert: What to Know as Battery Maker Dragonfly Energy Starts Trading
Dragonfly Energy (DFLI) stock is catching the interest of traders on Tuesday after the company's shares went public yesterday. 
Via InvestorPlace
Merck Collaborates Ginkgo Bioworks to Improve Active Pharmaceutical Ingredient Manufacturing
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.